Nanobiotix Sa ADR (NBTX) has released an update.
Nanobiotix Sa ADR has announced that it will release its financial and operational report for the fourth quarter and the full year of 2023 on April 24, 2024, with a follow-up conference call and webcast scheduled for April 25, 2024. The company, which specializes in innovative, physics-based cancer treatments, will have its CEO and CFO present the results and updates on business activities. Interested parties can access the webcast on Nanobiotix’s website and submit questions via email in advance.
For further insights into NBTX stock, check out TipRanks’ Stock Analysis page.
